| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.013 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |